The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting systemZheng Yang, Rong Li, Yuhuan Lv et al.|Nutrition Metabolism and Cardiovascular Diseases|2021Cited by 36
Sodium-glucose cotransporter-2 inhibitors and abnormal serum potassium: a real-world, pharmacovigilance studyYu Meng, Rong Li, Subei Zhao et al.|Journal of Cardiovascular Medicine|2024Cited by 2